Top ALK expert and cancer drug researcher Alice Shaw bids adieu to academia, hello to Novartis
Jay Bradner has recruited a marquee oncology drug researcher into the ranks of the Novartis Institutes for BioMedical Research. Alice Shaw is jumping from prestigious posts intertwined through Mass General, Harvard and Dana-Farber to take the lead of NIBR’s translational clinical oncology group.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 65,100+ biopharma pros reading Endpoints daily — and it's free.